MoneyWorks4Me

Unjha Formulations - Quaterly Results

04 Aug 2022 Evaluate
A decrease of about -36.12% in the sales to Rs. 24.87 millions was observed for the quarter ended June 2022. The sales stood at Rs. 38.93 millions during the similar quarter previous year.A radical decline of -91.11% was reported in the net profit of the company for the quarter ended June 2022 to Rs. 0.44  millions from Rs. 4.95 millions.A decline of 0.65 millions was observed in the OP in the quarter ended June 2022 from 5.19 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 24.87 38.93 -36.12 24.87 38.93 -36.12 143.51 101.72 41.08
Other Income 0.01 0.32 -96.88 0.01 0.32 -96.88 0.00 0.00 0.00
PBIDT 0.65 5.19 -87.48 0.65 5.19 -87.48 5.09 3.58 42.18
Interest 0.01 0.04 -75.00 0.01 0.04 -75.00 1.32 1.73 -23.70
PBDT 0.64 5.15 -87.57 0.64 5.15 -87.57 3.77 1.85 103.78
Depreciation 0.20 0.20 0.00 0.20 0.20 0.00 0.76 0.81 -6.17
PBT 0.44 4.95 -91.11 0.44 4.95 -91.11 3.01 1.04 189.42
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.44 4.95 -91.11 0.44 4.95 -91.11 2.54 1.04 144.23
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 2.61 13.33 -80.40 2.61 13.33 -80.40 3.55 3.52 0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..